ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted October 02, 2008

FDA Permits Incorrect Labeling on Generic Wellbutrin XL, But May Require Drug to be Tested

The FDA has acknowledged inconsistencies in the labeling of Budeprion XL, a generic version of the antidepressant Wellbutrin XL, according to an October 2, 2008 article from Dow Jones News service.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at www.consumerlab.com/join/